85岁及以上早期胃癌患者接受内镜黏膜下剥离术的预后因素
该单中心回顾性研究纳入2005年10月至2020年9月间143例85岁及以上接受内镜黏膜下剥离术的早期胃癌患者,评估长期结局与预后因素。中位年龄86岁,男性占65%,eCuraC-2率为14.7%。3年和5年总生存率分别为91.5%和74.7%,男性、ASA体能状态3级、BMI<18.9 kg/m2及eCuraC-2为独立预后因素。
要点
- 85岁及以上早期胃癌患者内镜黏膜下剥离术后5年总生存率为74.7%。
- 男性、ASA 3级、BMI<18.9 kg/m2及eCuraC-2是独立不良预后因素。
- eCuraC-2患者中不良预后因素显著多于非eCuraC-2患者。
核心结论
- 对于存在上述预后因素的患者,应慎重决定是否行内镜黏膜下剥离术,因为不进行内镜黏膜下剥离术而随访是可能的。
研究设计与样本
- 单中心回顾性研究,纳入2005年10月至2020年9月间143例85岁及以上接受内镜黏膜下剥离术的早期胃癌患者。
主要发现
- 中位年龄86岁,男性占65%,eCuraC-2率为14.7%。
- 随访期间55例死亡,其中仅2例死于胃癌。
- 3年和5年总生存率分别为91.5%和74.7%。
- 男性(风险比2.23;95%置信区间1.16-4.30)、美国麻醉医师协会体能状态3级(风险比2.57;95%置信区间1.32-4.99)、体重指数<18.9 kg/m2(风险比2.21;95%置信区间1.11-4.40)及eCuraC-2(风险比3.04;95%置信区间1.37-6.75)为独立预后因素。
- eCuraC-2患者的不良预后因素显著多于非eCuraC-2患者。
关键数值与推荐
- eCuraC-2定义为建议追加胃切除术。
- eCuraC-2率为14.7%。
- 3年总生存率91.5%,5年总生存率74.7%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Little is known about prognostic factors for patients 85 years or older undergoing endoscopic submucosal dissection for early gastric cancer. Therefore, this study aimed to identify such prognostic factors. METHODS: We retrospectively evaluated the long-term outcomes and prognostic factors of 143 patients 85 years or older undergoing endoscopic submucosal dissection for early gastric cancer at a single-center between October 2005 and September 2020. Using the Kaplan-Meier method and a Cox proportional hazards regression model, we examined the relationships of patient characteristics and endoscopic curability (additional gastrectomy recommended [eCuraC-2] or not recommended) with overall survival. RESULTS: The median age of the patients was 86 years, and most patients were men (65%). The eCuraC-2 rate was 14.7%. During the follow-up period, 55 patients died; however, only two patients died due to gastric cancer. The 3-year and 5-year overall survival rates were 91.5% and 74.7%, respectively. Male sex (hazard ratio, 2.23; 95% confidence interval, 1.16-4.30), American Society of Anesthesiologists Physical Status of 3 (hazard ratio, 2.57; 95% confidence interval, 1.32-4.99), body mass index < 18.9 kg/m2 (hazard ratio, 2.21; 95% confidence interval, 1.11-4.40), and eCuraC-2 (hazard ratio, 3.04; 95% confidence interval, 1.37-6.75) were identified as independent prognostic factors. Moreover, patients with eCuraC-2 had significantly more poor prognostic factors than those who did not. CONCLUSIONS: The decision to perform endoscopic submucosal dissection for patients with the aforementioned prognostic factors should be carefully considered because follow-up without endoscopic submucosal dissection is possible.
引用
- Izumi A, Horiuchi Y, Takamatsu M, et al. Prognostic factors for patients 85 years or older undergoing endoscopic submucosal dissection for early gastric cancer. Surg Endosc. 2024. PMID: 38872022. doi:10.1007/s00464-024-10935-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。